Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Acer Therapeutics Inc. See All Filings	D	2017-10-04 13:58:34 UTC
Amount To Be Raised $15,674,384 Associated Brokers / Dealers Piper Jaffray & Co. CIK Number 0001638234 Filed Document 0001638234-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-10-04 13:58:34 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Acer Therapeutics Inc. See All Filings	D	2017-04-05 15:14:22 UTC
Amount To Be Raised $5,500,000 Associated Brokers / Dealers N/A CIK Number 0001638234 Filed Document 0001638234-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-04-05 15:14:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Acer Therapeutics Inc. See All Filings	D/A	2016-05-06 00:00:00 UTC
Amount To Be Raised $8,149,999 Associated Brokers / Dealers N/A CIK Number 0001638234 Filed Document 0001638234-16-000003 Exclusions or Exemptions 506b Accepted Date 2016-05-06 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Acer Therapeutics Inc. See All Filings	D	2016-05-05 00:00:00 UTC
Amount To Be Raised $8,149,999 Associated Brokers / Dealers N/A CIK Number 0001638234 Filed Document 0001638234-16-000002 Exclusions or Exemptions 506b Accepted Date 2016-05-05 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Acer Therapeutics Inc. See All Filings	D	2015-04-01 00:00:00 UTC
Amount To Be Raised $2,100,000 Associated Brokers / Dealers N/A CIK Number 0001638234 Filed Document 0001638234-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-04-01 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt